Parametric Portfolio Associates’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
Other funds holding NYMX
FDCDDQ
E
PAG
HF
WB
LSA
Parametric Portfolio Associates's NYMX Position: Q3 2021 in Review
Parametric Portfolio Associates sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2021, closing a stake of 33,665 shares — an estimated $53K sold.
Parametric Portfolio Associates first reported a position in NYMX in Q1 2018 and held it in 14 quarters. The position peaked at $268K in Q3 2018. 38 funds tracked by Wall St. Rank hold NYMX as of Q3 2021.
- Parametric Portfolio Associates reported no remaining Nymox Pharmaceutical Corp position as of Q3 2021 after selling out during the quarter.
- Parametric Portfolio Associates sold 33,665 Nymox Pharmaceutical Corp shares in Q3 2021, an estimated $53K.
- Parametric Portfolio Associates first reported a position in Nymox Pharmaceutical Corp in Q1 2018 and held it in 14 quarters.
- Parametric Portfolio Associates's Nymox Pharmaceutical Corp position peaked at $268K in Q3 2018.
- 38 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2021.
Based on Parametric Portfolio Associates's 13F filing for Q3 2021, filed 15 Nov 2021.